Contrasting effects of cyclooxygenase-1 (COX-1) and COX-2 deficiency on the host response to influenza A viral infection

Journal of Immunology

Volumn 175, Issue 10, 2005, Pages 6878-6884

  Carey, Michelle A ^a   Bradbury, J Alyce ^a   Seubert, John M ^a   Langenbach, Robert ^a   Zeldin, Darryl C ^a   Germolec, Don R ^a  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; INFLUENZA VACCINE; LEUKOTRIENE; NONSTEROID ANTIINFLAMMATORY AGENT; PEPTIDOLEUKOTRIENE; PROSTAGLANDIN; PROSTAGLANDIN E2;

ADOLESCENT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY TEMPERATURE; BODY WEIGHT; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME DEFICIENCY; IMMUNE RESPONSE; IMMUNOMODULATION; INFLAMMATION; INFLUENZA VIRUS A; LUNG LAVAGE; MORTALITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; VIRUS INFECTION; VIRUS LOAD;

EID: 27744437942     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.175.10.6878     Document Type: Article

References (47)

1. Thompson, W. W., D. K. Shay, E. Weintraub, L. Brammer, N. Cox, L. J. Anderson, and K. Fukuda. 2003. Mortality associated with influenza and respiratory syncytial viras in the United States. J. Am. Med. Assoc. 289: 179-186.
2. Stohr, K. 2005. Avian influenza and pandemics-research needs and opportunities. N. Engl. J. Med. 352: 405-407.
3. Palese, P. 2004. Influenza: old and new threats. Nat. Med. 10: S82-S87.
4. Hashimoto, K., B. S. Graham, M. W. Geraci, G. A. FitzGerald, K. Egan, W. Zhou, K. Goleniewska, J. F. O'Neal, J. D. Morrow, R. K. Durbin, et al. 2004. Signaling through the prostaglandin 12 receptor IP protects against respiratory syncytial virus-induced illness. J. Virol. 78: 10303-10309.
5. Reddy, R. C., G. H. Chen, K. Tateda, W. C. Tsai, S. M. Phare, P. Mancuso, M. Peters-Golden, and T. J. Standiford. 2001. Selective inhibition of COX-2 improves early survival in murine endotoxemia but not in bacterial peritonitis. Am. J. Physiol. 281: L537-L543.
6. Aliberti, J., C. Serhan, and A. Sher. 2002. Parasite-induced lipoxin A4 is an endogenous regulator of IL-12 production and immunopathology in Toxoplasma gondii infection. J. Exp. Med. 196: 1253-1262.
7. Ejima, K., M. D. Layne, I. M. Carvajal, P. A. Kritek, R. M. Baron, Y. H. Chen, J. Vom Saal, B. D. Levy, S. F. Yet, and M. A. Perrella. 2003. Cyclooxygenase-2-deficient mice are resistant to endotoxin-induced inflammation and death. FASEB J. 17: 1325-1327.
8. Chen, N., A. Restivo, and C. S. Reiss. 2002. Selective inhibition of COX-2 is beneficial to mice infected intranasally with VSV. Prostaglandins Other Lipid Mediat. 67: 143-155.
9. 2 on allergic airway responses in the rat. J. Immunol. 169: 3963-3969.
10. 2 inhibits production of Th1 lymphokines but not of Th2 lymphokines. J. Immunol. 146: 108-113.
11. Luttmann, W., V. Herzog, H. Matthys, K. H. Thierauch, J. C. Virchow, and C. Kroegel. 1999. Modulation of cytokine release from mononuclear cells by prostacyclin, IL-4 and IL-13. Cytokine 11: 127-133.
12. Angeli, V., D. Staumont, A. S. Charbonnier, H. Hammad, P. Gosset, M. Pichavant, B. N. Lambrecht, M. Capron, D. Dombrowicz, and F. Trottein. 2004. Activation of the D prostanoid receptor 1 regulates immune and skin allergic responses. J. Immunol. 172: 3822-3829.
13. Noguchi, K., H. Endo, H. Kondo, and I. Ishikawa. 2001. Prostaglandin F2α upregulates interleukin-6 production in human gingival fibroblasts. J. Periodontal Res. 36: 80-87.
14. -/- mice. Am. J. Respir. Crit. Care Med. 167: 1509-1515.
15. Szczeklik, W., M. Sanak, and A. Szczeklik. 2004. Functional effects and gender association of COX-2 gene polymorphism G-765C in bronchial asthma. J. Allergy Clin. Immunol. 114: 248-253.
16. Cipollone, F., E. Toniato, S. Martinotti, M. Fazia, A. Iezzi, C. Cuccurallo, B. Fini, S. Ursi, G. Vitullo, M. Averna, et al. 2004. A polymorphism in the cyclooxygenase 2 gene as an inherited protective factor against myocardial infarction and stroke. J. Am. Med. Assoc. 291: 2221-2228.
17. Halushka, M. K., L. P. Walker, and P. V. Halushka. 2003. Genetic variation in cyclooxygenase 1: effects on response to aspirin. Clin. Pharmacol. Ther. 73: 122-130.
18. Warner, T. D., and J. A. Mitchell. 2004. Cyclooxygenases: new forms, new inhibitors, and lessons from the clinic. FASEB J. 18: 790-804.
19. Langenbach, R., S. G. Morham, H. F. Tiano, C. D. Loftin, B. I. Ghanayem, P. C. Chulada, J. F. Mahler, C. A. Lee, E. H. Goulding, K. D. Kluckman, et al. 1995. Prostaglandin synthase 1 gene disruption in mice reduces arachidonic acid-induced inflammation and indomethacin-induced gastric ulceration. Cell 83: 483-492.
20. Morham, S. G., R. Langenbach, C. D. Loftin, H. F. Tiano, N. Vouloumanos, J. C. Jennette, J. F. Mahler, K. D. Kluckman, A. Ledford, C. A. Lee, et al. 1995. Prostaglandin synthase 2 gene disruption causes severe renal pathology in the mouse. Cell 83: 473-482.
21. Loftin, C. D., D. B. Trivedi, H. F. Tiano, J. A. Clark, C. A. Lee, J. A. Epstein, S. G. Morham, M. D. Breyer, M. Nguyen, B. M. Hawkins, et al. 2001. Failure of ductus arteriosus closure and remodeling in neonatal mice deficient in cyclooxygenase-1 and cyclooxygenase-2. Proc. Natl. Acad. Sci. USA 98: 1059-1064.
22. Reed, L., and H. Muench. 1938. A simple method of estimating fifty percent endpoints. Am. J. Hygiene 27: 493-497.
23. Patriarca, P. A. 1994. A randomized controlled trial of influenza vaccine in the elderly. Scientific scrutiny and ethical responsibility. J. Am. Med. Assoc. 272; 1700-1701.
24. Dawson, T. C., M. A. Beck, W. A. Kuziel, F. Henderson, and N. Maeda. 2000. Contrasting effects of CCR5 and CCR2 deficiency in the pulmonary inflammatory response to influenza A virus. Am. J. Pathol. 156: 1951-1959.
25. Conn, C. A., J. L. McClellan, H. F. Maassab, C. W. Smitka, J. A. Majde, and M. J. Kluger. 1995. Cytokines and the acute phase response to influenza virus in mice. Am. J. Physiol. 268: R78-R84.
26. Fang, J., C. K. Sanborn, K. B. Renegar, J. A. Majde, and J. M. Krueger. 1995. Influenza viral infections enhance sleep in mice. Proc. Soc. Exp. Exp. Med. 210: 242-252.
27. Toth, L. A., J. E. Rehg, and R. G. Webster. 1995. Strain differences in sleep and other pathophysiological sequelae of influenza virus infection in naive and immunized mice. J. Neuroimmunol. 58: 89-99.
28. Toth, L. A., and M. R. Opp. 2001. Cytokine- and microbially induced sleep responses of interleukin-10 deficient mice. Am. J. Physiol. 280: R1806-R1814.
29. Van Reeth, K. 2000. Cytokines in the pathogenesis of influenza. Vet. Microbiol. 74: 109-116.
30. Alt, J. A., F. Obal, Jr., T. R. Traynor, J. Gardi, J. A. Majde, and J. M. Krueger. 2003. Alterations in EEG activity and sleep after influenza viral infection in GHRH receptor-deficient mice. J. Appl. Physiol. 95: 460-468.
31. Julkunen, I., T. Sareneva, J. Pirhonen, T. Ronni, K. Melen, and S. Matikainen. 2001. Molecular pathogenesis of influenza A virus infection and virus-induced regulation of cytokine gene expression. Cytokine Growth Factor Rev. 12: 171-180.
32. Kozak, W., H. Zheng, C. A. Conn, D. Soszynski, L. H. van der Ploeg, and M. J. Kluger. 1995. Thermal and behavioral effects of lipopolysaccharide and influenza in interleukin-1β-deficient mice. Am. J. Physiol. 269: R969-R977.
33. Kozak, W., V. Poli, D. Soszynski, C. A. Conn, L. R. Leon, and M. J. Kluger. 1997. Sickness behavior in mice deficient in interleukin-6 during turpentine abscess and influenza pneumonitis. Am. J. Physiol. 272: R621-R630.
34. Kelley, K. W., R. M. Bluthe, R. Dantzer, J. H. Zhou, W. H. Shen, R. W. Johnson, and S. R. Broussard. 2003. Cytokine-induced sickness behavior. Brain Behav. Immun. 17 (Suppl. 1): S112-S118.
35. Inui, A. 2001. Cytokines and sickness behavior: implications from knockout animal models. Trends Immunol. 22: 469-473.
36. Dooper, M. M., L. Wassink, L. M'Rabet, and Y. M. Graus. 2002. The modulatory effects of prostaglandin-E on cytokine production by human peripheral blood mononuclear cells are independent of the prostaglandin subtype. Immunology 107: 152-159.
37. + T cells. Ann. NY Acad. Sci. 795: 349-350.
38. Carey, M. A., D. R. Germolec, R. Langenbach, and D. C. Zeldin. 2003. Cyclooxygenase enzymes in allergic inflammation and asthma. Prostaglandins Leukot. Essent. Fatty Acids 69: 157-162.
39. Kunkel, S. L., R. C. Wiggins, S. W. Chensue, and J. Larrick. 1986. Regulation of macrophage tumor necrosis factor production by prostaglandin E2. Biochem. Biophys. Res. Commun. 137: 404-410.
40. Gavett, S. H., S. L. Madison, P. C. Chulada, P. E. Scarborough, W. Qu, J. E. Boyle, H. F. Tiano, C. A. Lee, R. Langenbach, V. L. Roggli, and D. C. Zeldin. 1999. Allergic lung responses are increased in prostaglandin H synthase-deficient mice. J. Clin. Invest. 104: 721-732.
41. Peters-Golden, M., C. Canetti, P. Mancuso, and M. J. Coffey. 2005. Leukotrienes: underappreciated mediators of innate immune responses. J. Immunol. 174: 589-594.
42. Machida, I., H. Matsuse, Y. Kondo, T. Kawano, S. Saeki, S. Tomari, Y. Obase, C. Fukushima, and S. Kohno. 2004. Cysteinyl leukotrienes regulate dendritic cell functions in a murine model of asthma. J. Immunol. 172: 1833-1838.
43. Bandeira-Melo, C., and P. F. Weller. 2003. Eosinophils and cysteinyl leukotrienes. Prostaglandins Leukot. Essent. Fatty Acids 69: 135-143.
44. Coffey, M., and M. Peters-Golden. 2003. Extending the understanding of leukotrienes in asthma. Curr. Opin. Allergy Clin. Immunol. 3: 57-63.
45. Volovitz, B., R. C. Welliver, G. De Castro, D. A. Krystofik, and P. L. Ogra. 1988. The release of leukotrienes in the respiratory tract during infection with respiratory syncytial virus: role in obstructive airway disease. Pediatr. Res. 24: 504-507.
46. Rice, P., E. Martin, J. R. He, M. Frank, L. DeTolla, L. Hester, T. O'Neill, C. Manka, I. Benjamin, A. Nagarsekar, et al. 2005. Febrile-range hyperthermia augments neutrophil accumulation and enhances lung injury in experimental gram-negative bacterial pneumonia. J. Immunol. 174: 3676-3685.
47. Fung-Leung, W. P., T. M. Kundig, R. M. Zinkernagel, and T. W. Mak. 1991. Immune response against lymphocytic choriomeningitis virus infection in mice without CD8 expression. J. Exp. Med. 174: 1425-1429.